UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Series A	Series A-1	Series B Preferred Stock	Class A Common Stock Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020						3,379,400	1,837,600
Beginning balance at Dec. 31, 2020						$ 7,789	$ 10,270
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of Preferred Stock (in shares)						(3,379,400)	(1,837,600)
Conversion of Preferred Stock						$ (7,789)	$ (10,270)
Ending balance (in shares) at Mar. 31, 2021						0	0
Ending balance at Mar. 31, 2021						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2020		95,050,041						4,681,400	0	0
Beginning balance at Dec. 31, 2020	$ (6,840)	$ 0	$ 4,975	$ 0	$ (35,815)			$ 24,000	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)		29,695,200						(4,681,400)
Conversion of Preferred Stock	18,058		42,058					$ (24,000)
Issuance of Class A Common Stock in connection with the Initial Public Offering, net of issuance costs (in shares)									10,000,000
Issuance of Class A Common Stock in connection with the initial public offering, net of $13,378 in issuance costs	126,622		126,622
Reclassification of Common Stock to Class B Common Stock in connection with the Initial Public Offering (in shares)		(124,745,241)								124,745,241
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering	0		(1)							$ 1
Exercise of stock options (in shares)										3,861
Exercise of stock options	7		7
Stock-based compensation expense	593		593
Foreign currency translation adjustments	0
Net (loss) income	1,471				1,471
Ending balance (in shares) at Mar. 31, 2021		0						0	10,000,000	124,749,102
Ending balance at Mar. 31, 2021	139,911	$ 0	174,254	0	(34,344)			$ 0	$ 0	$ 1
Beginning balance (in shares) at Dec. 31, 2021						0	0
Beginning balance at Dec. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Mar. 31, 2022						0	0
Ending balance at Mar. 31, 2022						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021		0						0	31,841,061	108,870,126
Beginning balance at Dec. 31, 2021	$ 225,542	$ 0	264,871	(230)	(39,100)			$ 0	$ 0	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)	0								10,842,862	(10,842,862)
Exercise of stock options (in shares)	197,828								197,828
Exercise of stock options	$ 924		924
Issuance of shares in connection with ESPP (in shares)									39,516
Vesting of Class A Common Stock in connection with Restricted Stock Units (in shares)	51,762								14,625
Stock-based compensation expense	$ 932		932
Foreign currency translation adjustments	(264)			(264)
Net (loss) income	(2,571)				(2,571)
Ending balance (in shares) at Mar. 31, 2022		0						0	42,935,892	98,027,264
Ending balance at Mar. 31, 2022	$ 224,563	$ 0	$ 266,727	$ (494)	$ (41,671)			$ 0	$ 0	$ 1